
A lot of confusion over biologic "birth products" and exosomes — Austin OrthoBiologics explains
Perhaps due to recent changes to FDA leadership with the new administration, there seems to be renewed interest in birth products, such as cord blood, placental tissue and Wharton's jelly, and their potential as orthobiologic treatments. Let's dive in...